TNF Pharma begins phase 2b clinical trial to evaluate oral TNF-alpha inhibitor drug candidate isomyosamine: Baltimore Thursday, February 27, 2025, 18:00 Hrs [IST] TNF Pharmaceutic ...
Hospital advertises for ‘corridor care doctor’ as A&E crisis deepens - Top doctor warns the need for the ad was a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback